Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_3
1
14%
Ph not_applicable
1
14%
Ph phase_4
2
29%
Ph phase_1
2
29%

Phase Distribution

2

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (33.3%)
Phase 31 (16.7%)
Phase 42 (33.3%)
N/A1 (16.7%)

Trials by Status

withdrawn114%
unknown114%
completed571%

Recent Activity

0 active trials
Showing 5 of 7
withdrawnphase_3

Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy

NCT06715462
completedphase_4

Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty

NCT03271151
completedphase_1

Bioavailability Study of Duloxetine Delayed-Relase Capsules 60 mg Under Fed Condition

NCT02291341
completedphase_1

Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fasting Condition

NCT02291367
completed

Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients

NCT02215798
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06715462Phase 3

Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy

Withdrawn
NCT03271151Phase 4

Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty

Completed
NCT02291341Phase 1

Bioavailability Study of Duloxetine Delayed-Relase Capsules 60 mg Under Fed Condition

Completed
NCT02291367Phase 1

Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fasting Condition

Completed
NCT02215798

Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients

Completed
NCT01269866Not Applicable

Study of Duloxetine in the Reduction of Pain in Patient With Systemic Lupus Erythematosus

Completed
NCT01078870Phase 4

Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk Genotype

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7